Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
JBM (Healthcare) Ltd. ( (HK:2161) ) has shared an announcement.
JBM (Healthcare) Limited has announced the updated list of its board of directors and their respective roles within the company, effective from October 2, 2025. This update reflects the company’s ongoing commitment to strong governance and strategic leadership, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:2161) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on JBM (Healthcare) Ltd. stock, see the HK:2161 Stock Forecast page.
More about JBM (Healthcare) Ltd.
Average Trading Volume: 1,081,044
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.41B
For detailed information about 2161 stock, go to TipRanks’ Stock Analysis page.